The latest price target for Ensysce Biosciences (NASDAQ:ENSC) was reported by HC Wainwright & Co. on September 25, 2023. The analyst firm set a price target for $7.00 expecting ENSC to fall to within 12 months (a possible -27.79% downside). 0 analyst firms have reported ratings in the last year.

The latest analyst rating for Ensysce Biosciences (NASDAQ:ENSC) was provided by HC Wainwright & Co., and Ensysce Biosciences maintained their buy rating.

There is no last upgrade for Ensysce Biosciences

There is no last downgrade for Ensysce Biosciences.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ensysce Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ensysce Biosciences was filed on September 25, 2023 so you should expect the next rating to be made available sometime around September 25, 2024.

While ratings are subjective and will change, the latest Ensysce Biosciences (ENSC) rating was a maintained with a price target of $9.00 to $7.00. The current price Ensysce Biosciences (ENSC) is trading at is $9.69, which is out of the analyst’s predicted range.